Our faculty research in diverse subjects: psychosomatic issues,
pain management, patient reporting and compliance behaviors, whole
community and family roles in psychiatric conditions and treatment,
teaching strategies and much more.
Steven Dubovsky, MD
Randomized, double-blind, parallel-group, placebo-controlled, dose ranging study of piromelatine in patients with mild dementia due to Alzheimer’s disease. Steven Dubovsky (Principal Investigator). Neurim Pharmaceuticals. $150,000. 1/1/2016-1/1/2018.
Access to Psychiatry Through Intermediate Care (APIC). Steven Dubovsky (Principal Investigator). Tower Foundation. $1,300,000. 1/1/2015-1/1/2017.
Open-label, long-term safety study of vilazodone in pediatric patients with major depressive disorder. Steven Dubovsky (Principal Investigator). Forest Research Institute. $221,000. 1/1/2015-1/1/2018.
In this custom-designed psychophysiology lab, our faculty,
residents and fellows study the mechanisms by which the mind
affects the body in psychosomatic illness by measuring heart rate
and heart rate variability under lab stress conditions.